Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)
Sponsored by Sequenom, Inc.
About this trial
Last updated 12 years ago
Study ID
SQNM-AMD-103
Status
Completed
Type
Observational
Placebo
No
Accepting
60+ Years
All
Trial Timing
Ended 12 years ago
What is this trial about?
Subjects with wet AMD, dry AMD, and age-matched controls will undergo routine occular
measurements, will provide a blood and cheek cell sample, and will have macular pigment
optical density (MPOD) measured to determine if there is an association between genetics,
MPOD and the risk of progression to wet AMD.
What are the participation requirements?
Inclusion Criteria
- subject is diagnosed with either CNV, dry AMD or is an age-matched control
- self reported as non-Hispanic Caucasian
- 60 years of age or older
- provides signed and dated informed consent
- agrees to provide 10 mL of whole blood and two buccal swabs
Exclusion Criteria
- previous donation under this protocol